Bachem Holding AG (BANB.SW) SIX

53.80

-1.1(-2.00%)

Updated at October 21 01:56PM

Currency In CHF

Bachem Holding AG

Address

Hauptstrasse 144

Bubendorf, 4416

Switzerland

Phone

41 58 595 2021

Sector

Basic Materials

Industry

Chemicals

Employees

2207

First IPO Date

July 17, 1998

Key Executives

NameTitlePayYear Born
Mr. Thomas MeierChief Executive Officer, Chief Operating Officer & Chairman of Group Executive Board587,0001968
Mr. Boris CorpatauxVice President & Head Global Strategic Alliances0N/A
Dr. Torsten WohrChief Commercial Officer01968
Dr. Gunther LoidlChief Technology Officer01970
Dr. Anne-Kathrin Stoller Ph.D.Chief Operating Officer of Bachem Americas, Inc.01974
Viviane MindenChief Human Resources Officer0N/A
Dr. Daniel GrotzkyHead of Group Communications0N/A
Mr. Achim PluckebaumChief Information Officer0N/A
Mr. Michael SuterVice President of Global Accounting0N/A
Mr. Alain SchaffterChief Financial Officer01977

Description

Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.